New York Life Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.8M | Buy |
241,308
+3,879
| +2% | +$720K | 0.42% | 42 |
|
|
2025
Q1 | $49.7M | Sell |
237,429
-828
| -0.3% | -$173K | 0.51% | 36 |
|
|
2024
Q4 | $42.3M | Buy |
238,257
+2,072
| +0.9% | +$368K | 0.41% | 42 |
|
|
2024
Q3 | $46.6M | Sell |
236,185
-7,474
| -3% | -$1.48M | 0.45% | 39 |
|
|
2024
Q2 | $41.8M | Buy |
243,659
+1,345
| +0.6% | +$231K | 0.42% | 38 |
|
|
2024
Q1 | $44.1M | Sell |
242,314
-9,304
| -4% | -$1.69M | 0.44% | 41 |
|
|
2023
Q4 | $39M | Sell |
251,618
-17,093
| -6% | -$2.65M | 0.4% | 46 |
|
|
2023
Q3 | $40.1M | Sell |
268,711
-319
| -0.1% | -$47.6K | 0.43% | 41 |
|
|
2023
Q2 | $36.2M | Buy |
269,030
+61
| +0% | +$8.22K | 0.38% | 46 |
|
|
2023
Q1 | $42.9M | Sell |
268,969
-1,071
| -0.4% | -$171K | 0.48% | 38 |
|
|
2022
Q4 | $43.6M | Sell |
270,040
-177
| -0.1% | -$28.6K | 0.5% | 35 |
|
|
2022
Q3 | $36.3M | Sell |
270,217
-762
| -0.3% | -$102K | 0.44% | 39 |
|
|
2022
Q2 | $41.5M | Buy |
+270,979
| New | +$41.5M | 0.48% | 35 |
|
|
2015
Q4 | – | Sell |
-11,412
| Closed | -$621K | – | 54 |
|
|
2015
Q3 | $621K | Buy |
11,412
+551
| +5% | +$30K | 0.06% | 74 |
|
|
2015
Q2 | $730K | Buy |
10,861
+895
| +9% | +$60.2K | 0.08% | 68 |
|
|
2015
Q1 | $583K | Hold |
9,966
| – | – | 0.07% | 77 |
|
|
2014
Q4 | $652K | Sell |
9,966
-2,917
| -23% | -$191K | 0.08% | 79 |
|
|
2014
Q3 | $744K | Hold |
12,883
| – | – | 0.12% | 57 |
|
|
2014
Q2 | $727K | Buy |
+12,883
| New | +$727K | 0.12% | 59 |
|